These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16641525)

  • 21. ART regimes and fat: the healing hand wielding the sword.
    Domingo P; Espinet J; Vidal F
    Lancet HIV; 2017 Jan; 4(1):e2-e3. PubMed ID: 27815067
    [No Abstract]   [Full Text] [Related]  

  • 22. Current perspectives on the management and prevention of antiretroviral-associated lipoatrophy.
    Phillips DR; Hay P
    J Antimicrob Chemother; 2008 Nov; 62(5):866-71. PubMed ID: 18703527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis virus coinfection in the Strategic Management of Antiretroviral Therapy (SMART) study: a marker for nonliver, non-opportunistic disease mortality.
    Wyles DL
    Clin Infect Dis; 2008 Dec; 47(11):1476-8. PubMed ID: 18959495
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiovascular disease and toxicities related to HIV infection and its therapies.
    Zareba KM; Miller TL; Lipshultz SE
    Expert Opin Drug Saf; 2005 Nov; 4(6):1017-25. PubMed ID: 16255661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults With HIV Infection in the Era of Combination Antiretroviral Therapy.
    Mirani G; Williams PL; Chernoff M; Abzug MJ; Levin MJ; Seage GR; Oleske JM; Purswani MU; Hazra R; Traite S; Zimmer B; Van Dyke RB;
    Clin Infect Dis; 2015 Dec; 61(12):1850-61. PubMed ID: 26270680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complications of HIV disease and antiretroviral therapy.
    Currier JS; Havlir DV
    Top HIV Med; 2009; 17(2):57-67. PubMed ID: 19401608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CROI 2015: Complications of HIV Infection and Antiretroviral Therapy.
    Havlir DV; Currier JS
    Top Antivir Med; 2015; 23(1):56-65. PubMed ID: 25965312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular risks of antiretroviral therapies.
    Mondy K; Tebas P
    Annu Rev Med; 2007; 58():141-55. PubMed ID: 17217329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dermatologic adverse effects of antiretroviral therapy: recognition and management.
    Luther J; Glesby MJ
    Am J Clin Dermatol; 2007; 8(4):221-33. PubMed ID: 17645377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Key data from the 11th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV.
    Boehme RE; Cameron S
    Antivir Ther; 2009; 14(8):1195-208. PubMed ID: 20032550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current therapy of HIV.
    Potthoff AV; Brockmeyer NH
    J Dtsch Dermatol Ges; 2010 Jan; 8(1):45-56; quiz 57-8. PubMed ID: 20096060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 30-year-old man with HIV infection and fever with cough 2 months after starting antiretroviral therapy.
    Xhani D; Hage CA; Knox KS
    Chest; 2007 Jul; 132(1):354-7. PubMed ID: 17625099
    [No Abstract]   [Full Text] [Related]  

  • 34. Care of the HIV-positive patient in the emergency department in the era of highly active antiretroviral therapy.
    Venkat A; Piontkowsky DM; Cooney RR; Srivastava AK; Suares GA; Heidelberger CP
    Ann Emerg Med; 2008 Sep; 52(3):274-85. PubMed ID: 18358567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Considering metabolic issues when initiating HIV therapy.
    Wohl DA
    Curr HIV/AIDS Rep; 2007 Aug; 4(3):119-25. PubMed ID: 17883997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chronic HIV infection. Current therapeutic aspects].
    Vogel M; Rockstroh JK
    Internist (Berl); 2007 May; 48(5):519-24; quiz 525. PubMed ID: 17431573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do non-nucleoside reverse transcriptase inhibitors contribute to lipodystrophy?
    Nolan D
    Drug Saf; 2005; 28(12):1069-74. PubMed ID: 16329710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients who want to stop their medications: treatment interruptions in HIV infection.
    Ball SC
    AIDS Read; 2003 Jul; 13(7):317-9, 324, 342. PubMed ID: 12889449
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy.
    Falutz J
    Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):651-61. PubMed ID: 17710086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What does the term "HIV-associated lipodystrophy" mean?
    Marcason W
    J Am Diet Assoc; 2009 Feb; 109(2):364. PubMed ID: 19167963
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.